Catalyst Wire Dossier Catalyst Wire Dossier

Tazorac Gel 0.1%

tazarotene 0.1% gel · Stiefel, a GSK Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tazorac Gel 0.1%, covering 2017-06-23 to 2017-06-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris [Phase 1]

See pricing